Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children
Abstract
BACKGROUND: The measles-mumps-rubella vaccine has been associated with immune thrombocytopenia purpura in 2 small studies. METHODS: By using the Vaccine Safety Datalink, we identified measles-mumps-rubella-vaccinated children aged 1 to 18. A case of immune thrombocytopenia purpura was defined as a patient with a platelet count of < or = 50,000/microL with clinical bleeding and normal red and white blood cell indices. The immune thrombocytopenia purpura incidence rates during exposed (42 days after vaccination) and unexposed time periods were determined. A retrospective cohort of vaccinated children was used to determine incident rate ratios for children aged 1 to 18 years, 12 to 23 months, and 12 to 15 months. RESULTS: A total of 1,036,689 children received 1,107,814 measles-mumps-rubella vaccinations; there were 259 confirmed patients with immune thrombocytopenia purpura. Because only 5 exposed cases occurred after age 2, analyses were limited to children aged 12 to 23 months. Exposed patients aged 12 to 23 months had lower median platelet counts than those who were unexposed and had similar median duration of illness (11 vs 10 days). The incident rate ratio was highest for children aged 12 to 15 months at 7.10. The incident rate ratio for boys aged 12 to 15 months was 14.59, and the incident rate ratio for girls in the same age group was 3.22. Seventy-six percent of immune thrombocytopenia purpura cases in children aged 12 to 23 months were attributable to measles-mumps-rubella vaccination. This vaccine causes 1 case of immune thrombocytopenia purpura per every 40,000 doses. CONCLUSION: Measles-mumps-rubella vaccine that is given in the second year of life is associated with an increased risk of immune thrombocytopenia purpura.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In France 2008, 20 cases were classified as exposed and 43 as not exposed.
“Twenty cases had been classified as exposed and 43 as not exposed.”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as France 2008
Cites
Rates of pediatric injuries by 3-month intervals for children 0 to 3 years of age
Agran, P. F., Anderson, C., Winn, D., Trent, R., Walton-Haynes, L., & Thayer, S. (2003) · Pediatrics · doi:10.1542/peds.111.6.e683 · Cited by 398 · see citing works
Relative Incidence Estimation from Case Series for Vaccine Safety Evaluation
Farrington, P. (1995) · Biometrics · doi:10.2307/2533328 · Cited by 363 · see citing works
Chen, R. T., Glasser, J. W., Rhodes, P., Davis, R. L., Barlow, W. E., Thompson, R. S., Mullooly, J. P., BLACK, S. B., Shinefield, H. R., Vadheim, C. M., et al. (1997) · PEDIATRICS · doi:10.1542/peds.99.6.765 · Cited by 346 · see citing works
Kühne, T., Buchanan, G. R., Zimmerman, S. A., Michaels, L. A., Kohan, R., Berchtold, W., & Imbach, P. A. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00535-3 · Cited by 284 · see citing works
Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study
Kühne, T., Imbach, P. A., Bolton‐Maggs, P. H. B., Berchtold, W., Blanchette, V. S., & Buchanan, G. R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07219-1 · Cited by 246 · see citing works
Case Series Analysis of Adverse Reactions to Vaccines: A Comparative Evaluation
Farrington, P., Nash, J., & Miller, E. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008695 · Cited by 233 · see citing works
Short report: Idiopathic thrombocytopenic purpura and MMR vaccine
Miller, E. J. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.84.3.227 · Cited by 228 · see citing works
Adverse Events Associated with Childhood Vaccines
Institute of Medicine (1994) · National Academies Press eBooks · doi:10.17226/2138 · Cited by 214 · see citing works
Impact of Vaccines Universally Recommended for Children—United States, 1900-1998
(1999) · JAMA · doi:10.1001/jama.281.16.1482-jwr0428-2-1 · Cited by 165 · see citing works
MMR vaccine and idiopathic thrombocytopaenic purpura
Black, C., Kaye, J. A., & Jick, H. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01790.x · Cited by 137 · cited 3× · see citing works
“Total ITP cases, N 63 69 56 60 Gender, n (%) Male 33 (52) 31 (45) 30 (54) 29 (48) Female 30 (48) 38 (55) 26 (46) 31 (52) Platelet count at diagnosis (25th, 75th percentiles), per L 7000 (3000, 18 000) 8500 (3000, 18 500) 8000 (3000, 17 000) 7000 (4000, 16 000) Referral to hematologist, n (%) 52 (83) 51 (74) 48 (86) 48…”
Rosthøj, S., Hedlund‐Treutiger, I., Rajantie, J., Zeller, B., Jónsson, Ó. G., Elinder, G., Wesenberg, F., & Henter, J. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00245-2 · Cited by 121 · see citing works
Glanz, J. M., McClure, D. L., XU, S., Hambidge, S. J., LEE, M., KOLCZAK, M. S., KLEINMAN, K. P., Mullooly, J. P., & France, E. K. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.11.012 · Cited by 117 · see citing works
Day-to-Day Reactogenicity and the Healthy Vaccinee Effect of Measles-Mumps-Rubella Vaccination
Virtanen, M., Peltola, H., Paunio, M., & Heinonen, O. P. (2000) · PEDIATRICS · doi:10.1542/peds.106.5.e62 · Cited by 105 · see citing works
Acute Immune Thrombocytopenia (ITP) in Childhood: Retrospective and Prospective Survey in Germany
Sutor, A. H., Harms, A., & Kaufmehl, K. (2001) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2001-15255 · Cited by 91 · see citing works
Beeler, J. A., Varricchio, F. E., & Wise, R. P. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199601000-00020 · Cited by 84 · see citing works
Thrombocytopenia after immunization of Canadian children, 1992 to 2001
Jadavji, T., Scheifele, D. W., & Halperin, S. A. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000048961.08486.d1 · Cited by 64 · see citing works
Jonville‐Béra, A. ‐., AUTRET, E., Galy-Eyraud, C., & Hessel, L. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199601000-00010 · Cited by 57 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Xs and Y of immune responses to viral vaccines
Klein, S. L., Jedlicka, A., & Pekosz, A. S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70049-9 · Cited by 813 · see citing works
The ITP syndrome: pathogenic and clinical diversity
Cines, D. B., Bussel, J. B., Liebman, H. A., & Prak, E. T. L. (2009) · Blood · doi:10.1182/blood-2009-01-129155 · Cited by 809 · see citing works
Sex-based differences in immune function and responses to vaccination
Klein, S. L., Marriott, I., & Fish, E. N. (2015) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/tru167 · Cited by 548 · see citing works
Sex and Gender Differences in the Outcomes of Vaccination over the Life Course
Flanagan, K. L., Fink, A. L., Plebanski, M., & Klein, S. L. (2017) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060718 · Cited by 508 · see citing works
Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination
Lee, E., Cines, D. B., Gernsheimer, T., Kessler, C. M., Michel, M., Tarantino, M. D., Semple, J. W., Arnold, D. M., Godeau, B., Lambert, M. P., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26132 · Cited by 387 · see citing works
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub3 · Cited by 372 · see citing works
Kahn, M. G., Raebel, M. A., Glanz, J. M., Riedlinger, K., & Steiner, J. F. (2012) · Medical Care · doi:10.1097/mlr.0b013e318257dd67 · Cited by 260 · see citing works
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety
McNeil, M. M., Gee, J. M., Weintraub, E., Belongia, E. A., Lee, G. M., Glanz, J. M., Nordin, J. D., Klein, N. P., Baxter, R. P., Naleway, A. L., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.073 · Cited by 247 · see citing works
Vaccines for measles, mumps, rubella, and varicella in children
Pietrantonj, C. D., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub4 · Cited by 197 · see citing works
Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?
Vadalà, M., Poddighe, D., Laurino, C., & Palmieri, B. (2017) · The EPMA Journal · doi:10.1007/s13167-017-0101-y · Cited by 149 · see citing works
Ghebremichael‐Weldeselassie, Y., Whitaker, H., & Farrington, P. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811001531 · Cited by 128 · see citing works
Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project
Yih, W. K., Kulldorff, M., FIREMAN, B. H., Shui, I. M., Lewis, E. M., Klein, N. P., Baggs, J. M., Weintraub, E., Belongia, E. A., Naleway, A. L., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722i · Cited by 127 · see citing works
Mantadakis, E., Farmaki, E., & Buchanan, G. R. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.10.015 · Cited by 122 · see citing works
The Risk of Immune Thrombocytopenic Purpura After Vaccination in Children and Adolescents
O’Leary, S. T., Glanz, J. M., McClure, D. L., Akhtar, A. Z., Daley, M. F., Nakasato, C. C., Baxter, R. P., Davis, R. L., Izurieta, H. S., Lieu, T. A., et al. (2012) · PEDIATRICS · doi:10.1542/peds.2011-1111 · Cited by 117 · see citing works
Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database
Yong, M., Schoonen, W. M., Li, L., Kanas, G., Coalson, J. E., Mowat, F. S., Fryzek, J. P., & Kaye, J. A. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08176.x · Cited by 113 · see citing works
Vaccine administration and the development of immune thrombocytopenic purpura in children
Cecinati, V., Principi, N., Brescia, L. P., Giordano, P., & Esposito, S. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23601 · Cited by 108 · see citing works
Strategies for Improving Vaccine Communication and Uptake
O’Leary, S. T., Opel, D. J., Cataldi, J. R., Hackell, J. M., O’Leary, S. T., Campbell, J. D., Ardura, M. I., Banerjee, R., Bryant, K. A., Caserta, M. T., et al. (2024) · PEDIATRICS · doi:10.1542/peds.2023-065483 · Cited by 101 · see citing works
Glanz, J. M., France, E. K., Xu, S., Hayes, T., & Hambidge, S. J. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1129 · Cited by 93 · see citing works
Vaccines for measles, mumps, rubella, and varicella in children
Pietrantonj, C. D., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub5 · Cited by 100 · see citing works
Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral?
Anderson, E. J., Campbell, J. D., Creech, C. B., Frenck, R., Kamidani, S., Munoz, F. M., Nachman, S., & Spearman, P. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1425 · Cited by 89 · see citing works
Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine
Malayala, S. V., Mohan, G., Vasireddy, D., & Atluri, P. (2021) · Cureus · doi:10.7759/cureus.14099 · Cited by 79 · see citing works
Baker, M. A., Lieu, T. A., Li, L., Hua, W., Qiang, Y., Kawai, A. T., FIREMAN, B. H., Martin, D., & Nguyen, M. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu322 · Cited by 75 · see citing works
Gubernot, D. M., Jazwa, A., Niu, M. T., Baumblatt, J. A. G., Gee, J. M., Moro, P. L., Duffy, J., Harrington, T. A., McNeil, M. M., Broder, K. R., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.05.016 · Cited by 74 · see citing works
Adversomics: The Emerging Field of Vaccine Adverse Event Immunogenetics
Poland, G. A., Ovsyannikova, I. G., & Jacobson, R. M. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a6a511 · Cited by 73 · see citing works
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine
Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J.-M. S., & Tarantino, M. D. (2021) · Journal of Blood Medicine · doi:10.2147/jbm.s307047 · Cited by 67 · see citing works
Active surveillance for adverse events following immunization
Crawford, N. W., Clothier, H. J., Hodgson, K. A., Selvaraj, G., Easton, M. L., & Buttery, J. P. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2014.866895 · Cited by 67 · see citing works
Portuguese, A. J., Sunga, C., Kruse‐Jarres, R., Gernsheimer, T., & Abkowitz, J. L. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004957 · Cited by 65 · see citing works
Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines
Rinaldi, M., Perricone, C., Ortega-Hernandez, O.-D., Perricone, R., & Shoenfeld, Y. (2014) · Lupus · doi:10.1177/0961203313499959 · Cited by 65 · see citing works
Adverse Vaccinal Events in Dogs and Cats
Moore, G. E., & HogenEsch, H. (2010) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2010.02.002 · Cited by 60 · see citing works
Sukumaran, L., McNeil, M. M., Moro, P. L., Lewis, P. W., Winiecki, S. K., & Shimabukuro, T. T. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ061 · Cited by 59 · see citing works
Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany
Beleni, A.-I., & Borgmann, S. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081618 · Cited by 57 · see citing works
Clinical practice: immune thrombocytopenia in paediatrics
Labarque, V., & Geet, C. V. (2014) · European Journal of Pediatrics · doi:10.1007/s00431-013-2254-6 · Cited by 56 · see citing works
Strebel, P. M., Papania, M. J., Gastañaduy, P. A., & Goodson, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00037-7 · Cited by 55 · see citing works
Bertuola, F., Morando, C., Menniti-Ippolito, F., Da Cas, R., Capuano, A., Perilongo, G., & Da Dalt, L. (2010) · Drug Safety · doi:10.2165/11530350-000000000-00000 · Cited by 53 · see citing works
Safety of Measles-Containing Vaccines in 1-Year-Old Children
Klein, N. P., Lewis, E. M., FIREMAN, B. H., Hambidge, S. J., Naleway, A. L., Nelson, J. C., Belongia, E. A., Yih, W. K., Nordin, J. D., Hechter, R. C., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2014-1822 · Cited by 50 · see citing works
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Pietrantonj, C. D. (2013) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.1948 · Cited by 51 · see citing works
Andrews, N. J., Stowe, J., Miller, E., Svanström, H., Johansen, K., Bonhoeffer, J., & Hviid, A. P. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.009 · Cited by 47 · see citing works
Comparison of epidemiologic methods for active surveillance of vaccine safety
McClure, D. L., Glanz, J. M., Xu, S., Hambidge, S. J., Mullooly, J. P., & Baggs, J. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.074 · Cited by 44 · see citing works
Glanz, J. M., Newcomer, S. R., Jackson, M. L., Omer, S. B., Bednarczyk, R. A., Shoup, J. A., Destefano, F. R., Daley, M. F., Goddard, K., Panneton, M., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.10.082 · Cited by 42 · see citing works
Segal, Y., Dahan, S., Sharif, Κ., Bragazzi, N. L., Watad, ., & Amital, H. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.037 · Cited by 42 · see citing works
Kowalzik, F., Faber, J., & Knuf, M. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.051 · Cited by 37 · see citing works
David, P., & Shoenfeld, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.085 · Cited by 36 · see citing works
Recurrent Immune Thrombocytopenia After Influenza Vaccination: A Case Report
Hamiel, U., Kventsel, I., & Youngster, I. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0124 · Cited by 34 · see citing works
Pérez-Vilar, S., Weibel, D. M., Sturkenboom, M., BLACK, S. B., Maure, C. G., Castro, J. L., Bravo‐Alcántara, P., Dodd, C. N., Romio, S., de Ridder, M. A. J., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.012 · Cited by 35 · see citing works
Burn, E., Li, X., Delmestri, A., Jones, N., Duarte‐Salles, T., Reyes, C., Martínez‐Hernández, E., Martí, E., Verhamme, K. M. C., Rijnbeek, P. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34668-w · Cited by 42 · see citing works
Identifying optimal risk windows for self‐controlled case series studies of vaccine safety
Xu, S., Zhang, L., Nelson, J. C., Zeng, C. X., Mullooly, J. P., McClure, D. L., & Glanz, J. M. (2010) · Statistics in Medicine · doi:10.1002/sim.4125 · Cited by 32 · see citing works
Quantin, C., Benzenine, É., Velten, M., Huet, F., Farrington, P., & Tubert‐Bitter, P. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt207 · Cited by 32 · see citing works
Strebel, P. M., Papania, M. J., Fiebelkorn, A. P., & Halsey, N. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00028-8 · Cited by 31 · see citing works
Idiopathic Immune-Mediated Thrombocytopenia and Recent Vaccination in Dogs
Huang, A. A., Moore, G. E., & Scott‐Moncrieff, J. C. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2011.00850.x · Cited by 31 · see citing works
Vaccine-associated thrombocytopenia
Gan, G., Liu, H., Liang, Z., Zhang, G., Liu, X., & Ma, L. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.09.017 · Cited by 30 · see citing works
Niu, M. T., Ball, R., Woo, E. J., Burwen, D. R., Knippen, M. A., & Braun, M. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.10.044 · Cited by 29 · see citing works
Adverse events following immunization: real causality and myths
Principi, N., & Esposito, S. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1167869 · Cited by 26 · see citing works
Woo, E. J., Wise, R. P., Menschik, D., Shadomy, S. V., Iskander, J., Beeler, J. A., Varricchio, F. E., & Ball, R. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.051 · Cited by 25 · see citing works
Russo, G. M., Parodi, E., Farruggia, P., Notarangelo, L. D., Perrotta, S., Casale, M., Cesaro, S., Borrello, G. D., Vecchio, G. C. D., Giona, F., et al. (2024) · Blood transfusion · doi:10.2450/bloodtransfus.501 · Cited by 24 · see citing works
Yokomichi, H., Tanaka‐Taya, K., Koshida, R., Nakano, T., Yasui, Y., Mori, M., Ando, Y., Morino, S., Okuno, H., Satoh, H., et al. (2020) · International Journal of Hematology · doi:10.1007/s12185-020-02866-1 · Cited by 23 · see citing works
Hsieh, Y., & Lin, L. (2010) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(10)70138-6 · Cited by 23 · see citing works
de Freitas, D. R. C., Moura, E., Araújo, G. C. B., Cardoso, A. V., Scheidt, P., Ferraz, E., Madalosso, G., Chen, R. T., & Hatch, D. L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.095 · Cited by 23 · see citing works
POSTVACCINATION THROMBOCYTOPENIA IN CANADA
Sauve, L. J., Bettinger, J. A., Scheifele, D. W., Halperin, S. A., Vaudry, W., & LAW, B. J. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181d2bb45 · Cited by 23 · see citing works
Sex-Differential and Non-specific Effects of Vaccines Over the Life Course
Clair, L. A. S., Chaulagain, S., Klein, S. L., Benn, C. S., & Flanagan, K. L. (2023) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-35139-6_9 · Cited by 23 · see citing works
Koenig, H. C., Sutherland, A., Izurieta, H. S., & McGonagle, D. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.044 · Cited by 22 · see citing works
Black, C., Tagiyeva, N., Helms, P. J. B., & Moir, D. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12645 · Cited by 22 · see citing works
Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine
Gaignard, M., Lieberherr, S., Schoenenberger, A. W., & Benz, R. A. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000618 · Cited by 21 · see citing works
Lai, L. Y. H., Arshad, F., Areia, C. M., Alshammari, T. M., Alghoul, H., Casajust, P., Li, X., Dawoud, D., Nyberg, F., Pratt, N. L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837632 · Cited by 23 · see citing works
Krow‐Lucal, E., Marin, M., Shepersky, L., Bahta, L., Loehr, J., & Dooling, K. L. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7146a1 · Cited by 21 · see citing works
Okazaki, N., Takeguchi, M., Sonoda, K., Handa, Y., Kakiuchi, T., Miyahara, H., Akiyoshi, K., Korematsu, S., Suenobu, S., & Izumi, T. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.036 · Cited by 20 · see citing works
Self-controlled case series design in vaccine safety: a systematic review
Nie, X., Xu, L., Bai, Y., Liu, Z., Liu, Z., Farrington, P., & Zhan, S. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2020108 · Cited by 18 · see citing works
Use of Fixed Effects Models to Analyze Self-Controlled Case Series Data in Vaccine Safety Studies
Xu, S. (2012) · Journal of Biometrics & Biostatistics · doi:10.4172/2155-6180.s7-006 · Cited by 19 · see citing works
Do childhood vaccines cause thrombocytopenia?
Sauve, L. J., & Scheifele, D. W. (2009) · Paediatrics & Child Health · doi:10.1093/pch/14.1.31 · Cited by 18 · see citing works
Xu, S., Hambidge, S. J., McClure, D. L., Daley, M. F., & Glanz, J. M. (2013) · Statistics in Medicine · doi:10.1002/sim.5733 · Cited by 18 · see citing works
Vaccination and Risk of Childhood IgA Vasculitis
Piram, M., Chiappe, S. G., Madhi, F., Ulinski, T., & Mahr, A. (2018) · PEDIATRICS · doi:10.1542/peds.2018-0841 · Cited by 18 · see citing works
Martins, R. D. M., Camacho, L. A. B., Marcovistz, R., de Noronha, T. G., Maia, M. D. L. S., dos Santos, E. M., Barbosa, G. G., da Silva, A. M. V., de Souza, P. C. N. F., Lemos, M. C. F., et al. (2008) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762008000700014 · Cited by 18 · see citing works
Maure, C. G., Elango, V., BLACK, S. B., Pérez-Vilar, S., Castro, J. L., Bravo‐Alcántara, P., Molina-León, H. F., Weibel, D. M., Sturkenboom, M., ZUBER, P. L. F., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.085 · Cited by 17 · see citing works
Ho, W., Lee, C.-C., Chen, C.-J., Lu, M., Hu, F., Jou, S., Lin, D., & Lin, K. (2012) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3182282548 · Cited by 16 · see citing works
Reef, S. E., & Plotkin, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00038-0 · Cited by 16 · see citing works
Hanson, K. E., Marin, M., Daley, M. F., Groom, H. C., Jackson, L. A., Sy, L. S., Klein, N. P., DeSilva, M. B., Panagiotakopoulos, L., Weintraub, E., et al. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100268 · Cited by 15 · see citing works
Maro, J. C., Brown, J. S., Pan, G. J. D., & Kulldorff, M. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3618 · Cited by 15 · see citing works
Weißer, K., Barth, I., & Keller‐Stanislawski, B. (2009) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-009-0961-y · Cited by 15 · see citing works
Šubelj, M., Učakar, V., Kraigher, A., & Klavs, I. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.14.30187 · Cited by 15 · see citing works
Frequently asked questions on seven rare adverse events following immunization
D’Alò, G. L., Zorzoli, E., Capanna, A., Gervasi, G., Terracciano, E., Zaratti, L., & Franco, E. (2016) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2017.58.1.659 · Cited by 14 · see citing works
Bravo‐Alcántara, P., Pérez-Vilar, S., Molina-León, H. F., Sturkenboom, M., BLACK, S. B., ZUBER, P. L. F., Maure, C. G., Castro, J. L., Castellano, V. E., Chiarvetti, L., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.069 · Cited by 15 · see citing works
Davis, R. L. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5010168 · Cited by 14 · see citing works
Risk of immune hemolytic anemia in children following immunization
Naleway, A. L., Belongia, E. A., Donahue, J. G., Kieke, B. A., & Glanz, J. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.023 · Cited by 14 · see citing works
Platelet and Blood Vessel Disorders
Scott, J. P., & Montgomery, R. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00478-4 · Cited by 14 · see citing works
Special Feature: Countering Vaccine Misinformation
Danielson, L., Marcus, B., & Boyle, L. (2019) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000586176.77841.86 · Cited by 14 · see citing works
Reef, S. E., & Plotkin, S. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00052-3 · Cited by 13 · see citing works
Immunization Coverage Among Juvenile Justice Detainees
Gaskin, G. L., Glanz, J. M., Binswanger, I. A., & Anoshiravani, A. (2015) · Journal of Correctional Health Care · doi:10.1177/0885066615587790 · Cited by 13 · see citing works
Gender Differences in the Level of Antibodies to Measles Virus in Adults
Kostinov, P. M., Zhuravlev, I. P., Nn, F., Kostinova, A. M., Полищук, В. Б., Shmitko, D. A., Mashilov, V. C., Vlasenko, A. E., Ryzhov, A. A., & Kostinov, A. M. (2021) · Vaccines · doi:10.3390/vaccines9050494 · Cited by 10 · see citing works
Immune thrombocytopenia relapse post covid-19 vaccine in young male patient
Qasim, H., Ali, E., & Yassin, M. A. (2021) · IDCases · doi:10.1016/j.idcr.2021.e01344 · Cited by 10 · see citing works
Brown, A. C., & Moss, W. J. (2009) · Springer eBooks · doi:10.1007/978-3-642-02155-8_11 · Cited by 10 · see citing works
Real‐world, single‐center experience of SARS‐CoV‐2 vaccination in immune thrombocytopenia
Woolley, P., Tailor, A., Shah, R., Westwood, J., & Scully, M. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15704 · Cited by 10 · see citing works
Immune thrombocytopenic purpura reactivation after tick-borne encephalitis vaccination
Benz, R. A., Krause, M., & Taverna, C. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.068 · Cited by 10 · see citing works
Toward Better Vaccine Safety Data and Safer Vaccination
Braun, M. M. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3846 · Cited by 10 · see citing works
Evidencias científicas disponibles sobre la seguridad de las vacunas
Picazo, J. J., Fernández, J. A., Axpe, J. M. A., Ordóñez, D. B., Gurrea, A. B., José, X. B., Díez‐Domingo, J., Romo, F. G., Matos, T. H.-S., Ruíz-Contreras, J., et al. (2011) · Vacunas · doi:10.1016/s1576-9887(11)70002-4 · Cited by 9 · see citing works
Demonstration of background rates of three conditions of interest for vaccine safety surveillance
Wormsbecker, A. E., Johnson, C., Bourns, L., Harris, T. M., Crowcroft, N. S., & Deeks, S. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210833 · Cited by 8 · see citing works
Immune thrombocytopenic purpura following anti-rabies vaccines
Sharma, S. K., Seth, T., Agrawal, N., Mahapatra, M., & Mishra, P. P. (2011) · Platelets · doi:10.3109/09537104.2011.610910 · Cited by 8 · see citing works
Liu, C.-H., Yeh, Y., Huang, W., Chie, W., & Chan, K. A. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.090 · Cited by 7 · see citing works
Mentzer, D., Meyer, H. L., & Keller‐Stanislawski, B. (2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-013-1792-4 · Cited by 7 · see citing works
Zeng, C. X., Newcomer, S. R., Glanz, J. M., Shoup, J. A., Daley, M. F., Hambidge, S. J., & Xu, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt211 · Cited by 7 · see citing works
Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders
Zerbo, O., Modaressi, S., Goddard, K., Lewis, E. M., FIREMAN, B. H., Daley, M. F., Irving, S. A., Jackson, L. A., Donahue, J. G., Qian, L., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.03.031 · Cited by 7 · see citing works
Moss, W. J., & Strebel, P. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00038-4 · Cited by 6 · see citing works
- Authors
- France, E. K., Glanz, J., Xu, S., Hambidge, S., Yamasaki, K., Black, S. B., Marcy, M., Mullooly, J. P., Jackson, L. A., Nordin, J., Belongia, E. A., Hohman, K., Chen, R. T., Davis, R., & for the Vaccine Safety Datalink Team
- Affiliations
- Department of Preventive Medicine
- Kaiser Permanente (US)
- Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California
- Group Health Cooperative (US)
- Regions Hospital (US)
- Marshfield Clinic Research Foundation (US)
- Harvard Pilgrim Health Care (US)
- Centers for Disease Control and Prevention (US)
- ORCID
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-03-01
- Volume
- 121
- Issue
- 3
- Pages
- e687-e692
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2007741934
- Cited by
- 165
- References
- 17
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 7 · 2023: 11 · 2022: 14 · 2021: 16 · 2020: 6 · 2019: 3 · 2018: 3 · 2017: 9 · 2016: 6 · 2015: 11 · 2014: 8 · 2013: 14 · 2012: 12
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- idiopathic thrombocytopenic purpura, MMR vaccine, vaccine adverse events, children, platelet count, incidence rate ratio, attributable risk, infants, sex differences
- MeSH terms
- Adolescent, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Immunization Schedule, Male, Purpura, Thrombocytopenic, Registries, Retrospective Studies, Severity of Illness Index, United States, Cohort Studies, Incidence, Poisson Distribution, Age Distribution, Sex Distribution, Risk Assessment, Measles-Mumps-Rubella Vaccine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
